Four Days Left Until Raffles Medical Group Ltd (SGX:BSL) Trades Ex-Dividend

Readers hoping to buy Raffles Medical Group Ltd (SGX:BSL) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be two business days before the record date, which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important as the process of settlement involves at least two full business days. So if you miss that date, you would not show up on the company's books on the record date. This means that investors who purchase Raffles Medical Group's shares on or after the 13th of May will not receive the dividend, which will be paid on the 23rd of May.

The company's upcoming dividend is S$0.025 a share, following on from the last 12 months, when the company distributed a total of S$0.025 per share to shareholders. Looking at the last 12 months of distributions, Raffles Medical Group has a trailing yield of approximately 2.4% on its current stock price of S$1.04. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. We need to see whether the dividend is covered by earnings and if it's growing.

Our free stock report includes 1 warning sign investors should be aware of before investing in Raffles Medical Group. Read for free now.

If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Raffles Medical Group paid out more than half (75%) of its earnings last year, which is a regular payout ratio for most companies. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Over the last year it paid out 68% of its free cash flow as dividends, within the usual range for most companies.

It's positive to see that Raffles Medical Group's dividend is covered by both profits and cash flow, since this is generally a sign that the dividend is sustainable, and a lower payout ratio usually suggests a greater margin of safety before the dividend gets cut.

Check out our latest analysis for Raffles Medical Group

Click here to see the company's payout ratio, plus analyst estimates of its future dividends.

historic-dividend
SGX:BSL Historic Dividend May 8th 2025
Advertisement

Have Earnings And Dividends Been Growing?

Stocks with flat earnings can still be attractive dividend payers, but it is important to be more conservative with your approach and demand a greater margin for safety when it comes to dividend sustainability. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. It's not encouraging to see that Raffles Medical Group's earnings are effectively flat over the past five years. We'd take that over an earnings decline any day, but in the long run, the best dividend stocks all grow their earnings per share. Earnings growth has been slim and the company is paying out more than half of its earnings. While there is some room to both increase the payout ratio and reinvest in the business, generally the higher a payout ratio goes, the lower a company's prospects for future growth.

Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. Since the start of our data, 10 years ago, Raffles Medical Group has lifted its dividend by approximately 3.2% a year on average.

Final Takeaway

Should investors buy Raffles Medical Group for the upcoming dividend? Earnings per share have barely grown, and although Raffles Medical Group paid out over half its earnings and free cash flow last year, the payout ratios are within a normal range for most companies. It might be worth researching if the company is reinvesting in growth projects that could grow earnings and dividends in the future, but for now we're not all that optimistic on its dividend prospects.

With that being said, if dividends aren't your biggest concern with Raffles Medical Group, you should know about the other risks facing this business. For example - Raffles Medical Group has 1 warning sign we think you should be aware of.

Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SGX:BSL

Raffles Medical Group

Provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan.

Flawless balance sheet, good value and pays a dividend.

Advertisement

Weekly Picks

TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3637.3% undervalued
45 users have followed this narrative
18 users have commented on this narrative
22 users have liked this narrative
MA
CSG logo
Marek_Trnka on CSG ·

Czechoslovak Group - is it really so hot?

Fair Value:€5547.4% undervalued
43 users have followed this narrative
1 users have commented on this narrative
13 users have liked this narrative
AL
alex30free
SECARE logo
alex30free on Swedencare ·

The Compound Effect: From Acquisition to Integration

Fair Value:SEK 46.2850.0% undervalued
12 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

UN
unknown
SPY logo
unknown on State Street SPDR S&P 500 ETF Trust ·

The Concentration Trap: Why the S&P 500 Is No Longer a 'Safe' Diversifier

Fair Value:US$58915.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AL
alex30free
ITAB logo
alex30free on ITAB Shop Concept ·

Transformational Merger

Fair Value:SEK 44.8566.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
asaa
NAS logo
asaa on Norwegian Air Shuttle ·

Norwegian Air Shuttle's revenue will grow by 73.56% and profitability will soar

Fair Value:NOK 20091.2% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.887.4% undervalued
59 users have followed this narrative
5 users have commented on this narrative
25 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$603.2233.5% undervalued
1277 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0227.7% undervalued
1073 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
Advertisement